Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C. According to a team of researchers who examined Medicaid policies for hepatitis C virus treatment using sofosbuvir, more commonly known as Solvadi, most should change policy to improve access to the treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/X2539_dpnxU/150629180005.htm
Hepatitis C: Life-threatening barriers in access to breakthrough drugs in US
29 junio 2015
Volver